Delayed
NSE India S.E.
05:26:20 2024-07-01 EDT
|
5-day change
|
1st Jan Change
|
18.4
INR
|
+7.41%
|
|
+1.05%
|
-35.22%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
897.9
|
1,105
|
1,273
|
332.4
|
360.9
|
327.2
|
Enterprise Value (EV)
1 |
1,161
|
1,399
|
1,623
|
621.8
|
705.9
|
612.8
|
P/E ratio
|
26
x
|
28.1
x
|
37.8
x
|
43.8
x
|
105
x
|
79
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.46
x
|
0.59
x
|
0.8
x
|
0.2
x
|
0.18
x
|
0.22
x
|
EV / Revenue
|
0.6
x
|
0.75
x
|
1.02
x
|
0.38
x
|
0.36
x
|
0.41
x
|
EV / EBITDA
|
14.4
x
|
15
x
|
19.3
x
|
14.9
x
|
23.4
x
|
17.8
x
|
EV / FCF
|
-106
x
|
-60.5
x
|
-26.9
x
|
10.6
x
|
-12.5
x
|
5.93
x
|
FCF Yield
|
-0.94%
|
-1.65%
|
-3.72%
|
9.4%
|
-8.01%
|
16.9%
|
Price to Book
|
2.87
x
|
3.14
x
|
3.3
x
|
0.84
x
|
0.91
x
|
0.82
x
|
Nbr of stocks (in thousands)
|
17,268
|
17,268
|
17,268
|
17,268
|
17,268
|
17,268
|
Reference price
2 |
52.00
|
64.00
|
73.75
|
19.25
|
20.90
|
18.95
|
Announcement Date
|
4/30/18
|
8/24/19
|
6/18/20
|
7/21/21
|
8/5/22
|
5/26/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,945
|
1,876
|
1,598
|
1,648
|
1,981
|
1,486
|
EBITDA
1 |
80.54
|
92.93
|
84.16
|
41.6
|
30.2
|
34.39
|
EBIT
1 |
75.85
|
86.42
|
77.21
|
35.52
|
24.42
|
28.86
|
Operating Margin
|
3.9%
|
4.61%
|
4.83%
|
2.16%
|
1.23%
|
1.94%
|
Earnings before Tax (EBT)
1 |
51.76
|
54.63
|
45
|
10.22
|
4.654
|
5.551
|
Net income
1 |
34.53
|
39.43
|
33.66
|
7.626
|
3.48
|
4.161
|
Net margin
|
1.77%
|
2.1%
|
2.11%
|
0.46%
|
0.18%
|
0.28%
|
EPS
2 |
1.999
|
2.280
|
1.949
|
0.4400
|
0.2000
|
0.2400
|
Free Cash Flow
1 |
-10.92
|
-23.1
|
-60.41
|
58.45
|
-56.53
|
103.4
|
FCF margin
|
-0.56%
|
-1.23%
|
-3.78%
|
3.55%
|
-2.85%
|
6.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
140.49%
|
-
|
300.68%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
766.48%
|
-
|
2,484.86%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/18
|
8/24/19
|
6/18/20
|
7/21/21
|
8/5/22
|
5/26/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
263
|
293
|
349
|
289
|
345
|
286
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.26
x
|
3.157
x
|
4.149
x
|
6.957
x
|
11.42
x
|
8.303
x
|
Free Cash Flow
1 |
-10.9
|
-23.1
|
-60.4
|
58.5
|
-56.5
|
103
|
ROE (net income / shareholders' equity)
|
11.7%
|
11.9%
|
9.12%
|
1.96%
|
0.88%
|
1.04%
|
ROA (Net income/ Total Assets)
|
7.84%
|
8.15%
|
6.44%
|
2.99%
|
2.04%
|
2.27%
|
Assets
1 |
440.6
|
483.8
|
523
|
255.1
|
170.3
|
183.1
|
Book Value Per Share
2 |
18.10
|
20.40
|
22.40
|
22.80
|
23.00
|
23.20
|
Cash Flow per Share
2 |
0.0100
|
0.0300
|
0.0200
|
0
|
0.0100
|
0.0200
|
Capex
1 |
10.6
|
-
|
8.15
|
2.8
|
6.46
|
8.87
|
Capex / Sales
|
0.55%
|
-
|
0.51%
|
0.17%
|
0.33%
|
0.6%
|
Announcement Date
|
4/30/18
|
8/24/19
|
6/18/20
|
7/21/21
|
8/5/22
|
5/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -35.22% | 3.55M | | +2.53% | 99.64B | | -11.14% | 59.01B | | +75.71% | 48.81B | | +5.26% | 34.94B | | +0.61% | 31.15B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B |
Other Commodity Chemicals
|